Home initiation of breathing support for children with complex medical needs
Official title: Single Site Feasibility and Safety Study of Home Initiation of Noninvasive Positive Pressure Ventilation in Children With Medical Complexity
Run by The Hospital for Sick Children · NCT05881031 · Data updated 2026-11-12
This study is testing if starting breathing support at home for children with complex medical needs is safe and effective compared to starting it in the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Months to 215 Months |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | The Hospital for Sick Children Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | June 21, 2023 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2027 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT05881031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5-17 years with medical complexity who have been newly prescribed NiPPV and can tolerate an awake trial of the device.
✕Probably not a fit
Patients with severe cardiac disease, high risk of complications from NiPPV, or severe sleep-disordered breathing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility and safety of starting noninvasive positive pressure ventilation (NiPPV) for children with medical complexity (CMC) in their home environment, rather than in a hospital setting. The research involves randomly assigning participants to either home initiation of NiPPV with remote telemonitoring or the standard in-hospital polysomnography (PSG) method. By assessing the effectiveness of this innovative approach, the study aims to improve adherence to NiPPV and enhance the quality of life for CMC. The study focuses on children aged 5-17 years who are newly prescribed NiPPV and have tolerated an awake trial of the device.
Why it matters
Potential benefit: If successful, this approach could significantly improve the comfort and adherence of children using breathing support, leading to better health outcomes.
How similar studies have gone: While the standard initiation of NiPPV typically occurs in a hospital, this home-based approach is innovative and has not been widely tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 5-17 years old 2. Newly prescribed NiPPV 3. Tolerated awake NiPPV trial 4. Provides informed consent Exclusion Criteria: 1. Cardiac disease at risk of hemodynamic instability with NiPPV initiation (eg cardiac dysfunction (ejection fraction \<45%), pulmonary hypertension (mean pulmonary artery pressure ≥ 20 mmHg on right heart catheterization or suggestive echocardiogram findings in the opinion of a pediatric cardiologist), or single ventricle) 2. At high risk of complications with NiPPV in the opinion of the child's physician (eg pneumothorax and aspiration risk) 3. Severe sleep disordered breathing with peak CO2 ≥ 60mmHg or apnea-hypopnea index (AHI)≥ 30/hr (AHI measures the number of respiratory events per hour) 4. Participation in concurrent research study that may affect NiPPV adherence (proposed primary outcome of full study) 5. Exclusion of study participants if the caregiver or participant is not English speaking
Where it's running
-
The Hospital for Sick Children
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Reshma Amin, MD — The Hospital for Sick Children
- Study coordinator: Reshma Amin, MD
- Email: Reshma.Amin@sickkids.ca
- Phone: (416) 813-7654
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Tonsillectomy Added to Hypoglossal Nerve Stimulation for OSA with Lateral Wall Collapse
In adults with obstructive sleep apnea and side-wide airway collapse, this study tests whether adding tonsil removal to hypoglossal nerve stimulation helps more than hypoglossal nerve stimulation alone.
-
Combined upper-airway electrical stimulation with a drug combo for sleep apnea
This study tests whether adding a drug mix called AtoOxy to an existing hypoglossal nerve stimulation device helps people with sleep apnea sleep better.
-
Central Sleep Apnea in Heart Failure: How Mechanisms May Guide Treatment
This study tests whether combining positive airway pressure with a medication (trazodone) or oxygen can reduce central sleep apnea in Veterans with heart failure and ensure better breathing during sleep.
-
Comparing two methods to help children with sleep apnea
This study is testing whether a special mouth device can help children with sleep apnea sleep better compared to just using nasal care before their surgery.
-
Comparing pain control methods after tonsil surgery in children
This study is testing whether long-lasting pain medicine like methadone works better than short-lasting options like fentanyl and hydromorphone for controlling pain in kids and teens after tonsil surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.